Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of return on equity.
The trailing-twelve-month return on equity at Laboratory Corp of America Holdings LH is 24.61%. LH's PEG ratio is 1.24.
The trailing-twelve-month return on equity at Quest Diagnostics Incorporated DGX is 15.11%. DGX's revenue for the same period is $7.38 billion.
The trailing-twelve-month return on equity at Pharmaceutical Product Development Inc PPDI is 11.80%. PPDI's operating margin for the same period is 14.08%.
The trailing-twelve-month return on equity at Covance Inc CVD is 4.44%. CVD's operating margin for the same period is 9.33%.
Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROE
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in